Ecopharmacovigilance: Perspectives, concepts, applications, and relationships in modern context
Introduction: Environmental scientists have made great strides to regulate pharmaceutical waste. However, the monitoring of emerging environmental problems induced by drugs should attract the further interest of pharmacy and pharmacovigilance scientists. Ecopharmacovigilance (EPV) as a kind of pharmacovigilance for the atmosphere is widely recognized as essential to minimize the environmental impact of pharmaceutical toxins.
Methods: In efforts to answer the environmental issues created by medications, the constructive involvement of the pharmaceutical sector is essential. On a prioritized basis, EPV can target individual pharmaceuticals. For EPV deployment targeting pharmaceutical contamination, certain advice and management practice solutions are recommended. On administration certain drugs are metabolized throughout the bloodstream, being inert or becoming converted to metabolites, whereas others are excreted in the urine or liver and excreted in the sewage. The substances that are released into drainage can be processed into a number of chemicals by a sewage treatment process.
Results: The involvement of different drugs and their components have been found in the marine world, with the aquatic environment being the most researched to date. Nanostructure materials have been around for a long time, and their interactions with biological processes have been discussed in various applications to enhance the understanding and importance of environmental and health effects.
Conclusions: In order to regulate pharmaceutical residues in effluents, Technologies for sewage water management should be applied. In particular, the presence of pharmacy including pharmacovigilance professionals is also important for enhancing multidisciplinary collaboration.
Alshakka, M., Ibrahim, M. I., Hassali, M. A., Palaian, S., Aljadhey, H. (2016). Hazards of pharmaceuticals in water as new area in eco-pharmacovigilance research. Journal of pharmacy practice and community medicine, 2(1), 3-8.
Camacho-Munoz, D., Martín, J., Santos, J. L., Alonso, E., Aparicio, I., De la Torre, T., Rodriguez, C., Malfeito, J. J. (2012). Effectiveness of three configurations of membrane bioreactors on the removal of priority and emergent organic compounds from wastewater: comparison with conventional wastewater treatments. Journal of environmental monitoring, 14(5), 1428-36.
Cerro-Lopez, M., Mendez-Rojas, M. A. (2017). Application of nanomaterials for treatment of wastewater containing pharmaceuticals. In: Ecopharmacovigilance. Springer, Cham. 201-219.
Coetsier, C., Lin, L., Roig, B., & Touraud, E. (2007). Integrated approach to the problem of pharmaceutical products in the environment: an overview. Analytical and bioanalytical chemistry, 387(4), 1163–1166.
Gomez-Olivan, L. M. (2018). Ecopharmacovigilance: Multidisciplinary Approaches to Environmental Safety of Medicines. Cham, Switzerland: Springer, 2018.
Gupta, Y. K. (2010). Ensuring patient safety-launching the new pharmacovigilance programme of India. Pharma Times, 42(8), 21-26.
Halling-Sorensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lutzhoft, H. C., & Jorgensen, S. E. (1998). Occurrence, fate and effects of pharmaceutical substances in the environment--a review. Chemosphere, 36(2), 357–393.
He, B. S., Wang, J., Liu, J., & Hu, X. M. (2017). Eco-pharmacovigilance of non-steroidal anti-inflammatory drugs: Necessity and opportunities. Chemosphere, 181, 178–189.
Holm, G., Snape, J. R., Murray-Smith, R., Talbot, J., Taylor, D., & Sörme, P. (2013). Implementing ecopharmacovigilance in practice: challenges and potential opportunities. Drug safety, 36(7), 533–546.
Islas-Flores, H., Gomez-Olivan, L. M., SanJuan-Reyes, N., Elizalde-Velázquez, A., Dublan-Garcia, O., Galar-Martinez, M., Garcia-Medina, S., Hernandez-Navarro, M. D. (2017). Background to the Emergence of Ecopharmacovigilance. In: Ecopharmacovigilance. Springer, Cham, 13-20.
Jones, O. A., Voulvoulis, N., & Lester, J. N. (2001). Human pharmaceuticals in the aquatic environment a review. Environmental technology, 22(12), 1383–1394.
Kharisov, B. I., Kharissova, O. V., Ortiz-Mendez, U. (2016). CRC concise encyclopedia of nanotechnology. CRC Press, 2016.
Kümmerer K. (2003). Significance of antibiotics in the environment. The Journal of antimicrobial chemotherapy, 52(1), 5–7.
Kuspis, D. A., & Krenzelok, E. P. (1996). What happens to expired medications? A survey of community medication disposal. Veterinary and human toxicology, 38(1), 48–49.
Medhi, B., & Sewal, R. K. (2012). Ecopharmacovigilance: an issue urgently to be addressed. Indian journal of pharmacology, 44(5), 547–549.
Mendez-Rojas, M. A., Sanchez-Salas, J. L., Angulo-Molina, A., Palacios-Hernandez, T. D. (2014). Environmental risks of nanotechnology: evaluating the ecotoxicity of nanomaterials. Nanomaterials for Environmental Protection. John Wiley & Sons, Hoboken, NJ, 503-17.
Nieto, A., Borrull, F., Pocurull, E., & Marcé, R. M. (2010). Occurrence of pharmaceuticals and hormones in sewage sludge. Environmental toxicology and chemistry, 29(7), 1484–1489.
Patneedi, C. B., Prasadu, K. D. (2015). Impact of pharmaceutical wastes on human life and environment. Rasayan journal of chemistry, 8(1), 67-70.
Rodil, R., Quintana, J. B., Concha-Graña, E., López-Mahía, P., Muniategui-Lorenzo, S., & Prada-Rodríguez, D. (2012). Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain). Chemosphere, 86(10), 1040–1049.
Silva, L. J., Lino, C. M., Meisel, L., Barcelo, D., Pena, A. (2011). Ecopharmacovigilance. In: Emerging organic contaminants and human health. Springer, Berlin, Heidelberg, 213-241.
Swan, G. E., Cuthbert, R., Quevedo, M., Green, R. E., Pain, D. J., Bartels, P., Cunningham, A. A., Duncan, N., Meharg, A. A., Oaks, J. L., Parry-Jones, J., Shultz, S., Taggart, M. A., Verdoorn, G., & Wolter, K. (2006). Toxicity of diclofenac to Gyps vultures. Biology letters, 2(2), 279–282.
Velo, G. (2017). Ecopharmacovigilance. In: Pharmacovigilance; Adis, Cham, 195-205.
Wang, J., & Hu, X. (2014). Ecopharmacovigilance: Current state, challenges, and opportunities in China. Indian journal of pharmacology, 46(1), 13–17.
Wang, J., Li, S., & He, B. (2020). Chinese physicians' attitudes toward eco-directed sustainable prescribing from the perspective of ecopharmacovigilance: a cross-sectional study. BMJ open, 10(6), e035502.
Copyright (c) 2021 Prachi Khamkar, Debarshi Kar Mahapatra, Atul Kadam
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.